A Case Report of Sustained Cytokine Release Syndrome Due to Glofitamab and Literature Review
Jingyi Yang,1– 3,* Qian Shen,1,4,* Xiaoyan Ke,5 Wei Liu,1,3 Ping Yang5 1Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, People’s Republic of China; 2Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences, Peking Univer...
Saved in:
| Main Authors: | Yang J, Shen Q, Ke X, Liu W, Yang P |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Clinical Pharmacology: Advances and Applications |
| Subjects: | |
| Online Access: | https://www.dovepress.com/a-case-report-of-sustained-cytokine-release-syndrome-due-to-glofitamab-peer-reviewed-fulltext-article-CPAA |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sarilumab is not Inferior to Tocilizumab in the Treatment of Cytokine Release Syndrome in COVID-19
by: V. T. Ivashkin, et al.
Published: (2023-12-01) -
Cytokine release syndrome caused by immune checkpoint inhibitors: a case report and literature review
by: Xiuping Zhang, et al.
Published: (2024-12-01) -
Efficacy of sarilumab and dexamethasone co-administration for lowering multiple blood biomarkers in the treatment of cytokine release syndrome in hospitalized covid-19 patients
by: Ishtiaq Ahmad, et al.
Published: (2024-06-01) -
In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
by: Anett Pfeiffer, et al.
Published: (2018-09-01) -
Cytokine release syndrome and CAR T Cell therapy: Modulating the intensity of the inflammatory response and resolution within the tumor microenvironment
by: David F. Driscoll, et al.
Published: (2025-06-01)